Purchase Order SPE2DS25V263U
- Not listed
- The U.S. Defense Department's Medical Supply Chain, through its Defense Logistics Agency, awarded a $1,148.65 firm fixed-price purchase order to Fenwal, Inc. for blood collection assemblies. The contract, issued on September 16, 2025, with an ultimate completion date of September 22, 2025, carries no set-aside designation and represents a competitive award to the prime contractor. Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi headquartered in Lake Zurich,...
- Fenwal, Inc., a Lake Zurich, Illinois-based blood technology company and subsidiary of Fresenius Kabi, was awarded a $1,101.28 firm fixed-price purchase order by the Defense Logistics Agency (DLA) on June 18, 2025, for a blood pack with anticoagulant. The contract, which carries an ultimate completion date of August 18, 2025, represents a continuation of Fenwal's established role as a critical supplier of specialized blood collection and transfusion products to the federal government. This award...
- This federal contract award, valued at $2,570.40, was issued by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi located in Lake Zurich, Illinois. The contract is a firm fixed-price purchase order for the supply of specialized medical products, such as blood collection assemblies, washing solutions, and apheresis equipment, to support critical healthcare programs, including military medical supply chains, biomedical research...
- The Defense Logistics Agency Troop Support Medical awarded a $5,315 purchase order to Fenwal, Inc. for blood collection assistance under contract number 8510129642. The firm fixed price contract calls for Fenwal to provide the requested products and services from their facility in Lake Zurich, Illinois, with performance spanning from September 7th through 12th, 2023. As a major supplier of blood collection and transfusion equipment to the Department of Defense, Fenwal will likely deliver medical...
- Fenwal, Inc., a blood technology company and subsidiary of Fresenius Kabi, was awarded a firm fixed-price purchase order valued at $1,871.34 by the Defense Logistics Agency's Medical Supply Chain on July 30, 2025. The contract calls for the delivery of a hand blood sealer, a specialized medical device used in blood collection and processing operations. The award is not designated as a set-aside contract, reflecting Fenwal's competitive standing in federal procurement. Performance will be...
- The U.S. government awarded a firm-fixed-price purchase order contract to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi located in Lake Zurich, Illinois. The $85,899.84 contract is to provide blood packs with anticoagulant to the Defense Logistics Agency (DLA), which serves as the medical supply chain for the U.S. Department of Defense. The contract has an ultimate completion date of July 21, 2025 and was awarded on May 22, 2025. Fenwal, Inc. is a registered...
- This is a federal purchase order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Fenwal, Inc., a subsidiary of Fresenius Kabi, for the supply of various blood collection and transfusion-related products and services. The contract, valued at $4,594.60, has an ultimate completion date of October 22, 2024. Fenwal, a global blood technology company, has been a registered vendor with the U.S. federal government since 2007 and has established itself as a key supplier to...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price purchase order contract to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The $2,353.50 contract, awarded on May 30, 2024, is for the delivery of medical supplies and equipment such as washing solutions, diluting solutions, anticoagulants, blood collection assemblies, donor tubing strippers, and other products supporting transfusion medicine and cell therapy applications....
- This federal contract award, valued at $18,378.40, was issued by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the delivery of various blood collection supplies, including blood collection assemblies, washing solutions, diluting solutions, anticoagulant citrate products, donor tubing strippers, plasma extractors, blood pack sealers, and centrifuging bags. The contract has an ultimate completion date...
- This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a foreign-owned, for-profit manufacturer of specialized medical equipment and consumables for the blood and biomedical research supply chain. The $1,148.65 contract is for the supply of blood collection assemblies and related products to support critical healthcare programs, including military medical supply chains and biomedical research initiatives. The contract has an ultimate...
The U.S. Department of Defense's Medical Supply Chain awarded a firm fixed-price purchase order valued at $11,486.50 to Fenwal, Inc. for blood collection assemblies. The contract was executed on September 25, 2025, with an ultimate completion date of September 30, 2025. No set-aside designation was applied to this award. Fenwal, Inc., a subsidiary of Fresenius Kabi headquartered in Lake Zurich, Illinois, serves as the prime contractor and will perform all work at its Illinois facility. Fenwal, Inc. is an established global blood technology company specializing in blood collection, separation, storage, and transfusion products and services. The company has maintained federal vendor registration since 2007 and has consistently secured contracts from multiple defense and civilian agencies, including the Defense Logistics Agency, National Institutes of Health, the Defense Health Agency, and the Department of Veterans Affairs. This award reflects Fenwal's ongoing role as a critical supplier of specialized medical equipment and consumables that support military medical supply chains and healthcare initiatives across the federal government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.5k | 9/25/25 |